Hanmi Science Co., Ltd. (KRX:008930)
South Korea · Delayed Price · Currency is KRW 33,500
-650 (-1.90%)
Last updated: May 19, 2026, 3:00 PM KST
Hanmi Science Company Description
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally.
It develops drugs in the areas of diabetes and anti-cancer. The company also offers drug substances, general medicines, health functional foods, and nutrition and health products and services.
In addition, it operates an online pharmacy; and offers pharmaceutical management automation systems.
The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012.
Hanmi Science Co., Ltd. was founded in 1973 and is based in Seoul, South Korea.
Hanmi Science Co., Ltd.
| Country | South Korea |
| Founded | 1973 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| CEO | Jong-Hoon Lim |
Contact Details
Address: 14 Wiryeseong-daero Seoul South Korea | |
| Phone | 82 2 410 9114 |
Stock Details
| Ticker Symbol | 008930 |
| Exchange | Korea Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7008930000 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Jong-Hoon Lim | Chief Executive Officer |
| Ju-Hyun Lim | President and Inside Director |
| Chan Seob Kim | Chief Financial Officer and Senior MD |